CCI Approves TPG Scion’s Acquisition of Schott Poonawalla Stake
ECONOMY & POLICY

CCI Approves TPG Scion’s Acquisition of Schott Poonawalla Stake

The Competition Commission of India (CCI) has approved the proposed acquisition of a stake in Schott Poonawalla Private Limited (SPPL) by TPG Scion SG Pte. Ltd., marking a significant development in the pharmaceutical packaging sector. The acquisition will be executed through a secondary share purchase from Serum Institute of India Private Limited.

TPG Scion SG Pte. Ltd. is a newly established special-purpose investment vehicle incorporated in Singapore on 11th October 2024, specifically for this transaction. Currently, it has no operational presence in India. It is affiliated with the TPG Group, a global, diversified investment firm founded in 1992. The TPG Group, which operates across multiple asset classes including private equity, real estate, and infrastructure, manages investments worldwide. The transaction is ultimately controlled by an entity advised by affiliates of TPG Inc., the ultimate holding company of the group.

Schott Poonawalla Private Limited (SPPL), the target company, is engaged in the development, manufacturing, and sale of pharmaceutical packaging solutions. Its product portfolio includes sterile and non-sterile glass containers such as ampoules, vials, cartridges, and prefilled syringes, which are critical components for the pharmaceutical and biotechnology industries. The company specialises in converting tubular glass into primary packaging solutions, ensuring high standards of safety and integrity for pharmaceutical formulations.

Strategic Importance of the Acquisition The acquisition aligns with TPG’s strategy of investing in high-growth sectors, particularly healthcare and life sciences. With India being a global leader in pharmaceutical manufacturing, the demand for high-quality primary packaging solutions has surged, driven by the rise in vaccine production, biologics, and injectable therapies.

The CCI’s approval paves the way for enhanced investments, technological advancements, and global expertise infusion in India's pharmaceutical packaging segment. The partnership between TPG and SPPL is expected to strengthen supply chain efficiencies, improve manufacturing capabilities, and support innovation in sterile and injectable packaging solutions.

Market and Industry Outlook India’s pharmaceutical packaging market is witnessing robust growth, propelled by increasing regulatory requirements, demand for biologics, and the rise of single-dose drug delivery systems. The expansion of vaccine production and the growth of biosimilars and novel therapies have amplified the need for advanced packaging solutions.

With global investors such as TPG entering the segment, the industry is poised for enhanced technological collaborations, automation in manufacturing, and sustainable packaging innovations. The acquisition of a stake in Schott Poonawalla Private Limited is expected to strengthen India’s position as a global hub for pharmaceutical packaging, ensuring compliance with stringent international standards while catering to the evolving needs of the pharmaceutical industry.

The Competition Commission of India (CCI) has approved the proposed acquisition of a stake in Schott Poonawalla Private Limited (SPPL) by TPG Scion SG Pte. Ltd., marking a significant development in the pharmaceutical packaging sector. The acquisition will be executed through a secondary share purchase from Serum Institute of India Private Limited. TPG Scion SG Pte. Ltd. is a newly established special-purpose investment vehicle incorporated in Singapore on 11th October 2024, specifically for this transaction. Currently, it has no operational presence in India. It is affiliated with the TPG Group, a global, diversified investment firm founded in 1992. The TPG Group, which operates across multiple asset classes including private equity, real estate, and infrastructure, manages investments worldwide. The transaction is ultimately controlled by an entity advised by affiliates of TPG Inc., the ultimate holding company of the group. Schott Poonawalla Private Limited (SPPL), the target company, is engaged in the development, manufacturing, and sale of pharmaceutical packaging solutions. Its product portfolio includes sterile and non-sterile glass containers such as ampoules, vials, cartridges, and prefilled syringes, which are critical components for the pharmaceutical and biotechnology industries. The company specialises in converting tubular glass into primary packaging solutions, ensuring high standards of safety and integrity for pharmaceutical formulations. Strategic Importance of the Acquisition The acquisition aligns with TPG’s strategy of investing in high-growth sectors, particularly healthcare and life sciences. With India being a global leader in pharmaceutical manufacturing, the demand for high-quality primary packaging solutions has surged, driven by the rise in vaccine production, biologics, and injectable therapies. The CCI’s approval paves the way for enhanced investments, technological advancements, and global expertise infusion in India's pharmaceutical packaging segment. The partnership between TPG and SPPL is expected to strengthen supply chain efficiencies, improve manufacturing capabilities, and support innovation in sterile and injectable packaging solutions. Market and Industry Outlook India’s pharmaceutical packaging market is witnessing robust growth, propelled by increasing regulatory requirements, demand for biologics, and the rise of single-dose drug delivery systems. The expansion of vaccine production and the growth of biosimilars and novel therapies have amplified the need for advanced packaging solutions. With global investors such as TPG entering the segment, the industry is poised for enhanced technological collaborations, automation in manufacturing, and sustainable packaging innovations. The acquisition of a stake in Schott Poonawalla Private Limited is expected to strengthen India’s position as a global hub for pharmaceutical packaging, ensuring compliance with stringent international standards while catering to the evolving needs of the pharmaceutical industry.

Next Story
Infrastructure Transport

Leh Airport Goes Green

Leh Kushok Bakula Rinpoche Airport is set to become India’s first airport powered by geothermal and solar energy, marking a significant milestone in sustainable aviation. This initiative, undertaken at an estimated cost of Rs 6.50 billion, aligns with efforts to transform Ladakh into a carbon-neutral region. With airports being major energy consumers, this project represents a crucial step toward reducing carbon emissions in aviation infrastructure.  The airport’s innovative approach involves replacing conventional air-conditioning systems with underfloor heating using geothermal..

Next Story
Infrastructure Urban

CCI Clears Tata Sons' Additional Stake Buy in Tata Play from Baytree

The Competition Commission of India has approved the acquisition of certain additional shareholding in Tata Play (Tata Play) by Tata Sons (Tata Sons) from Baytree Investments (Mauritius).The Proposed Combination involves the acquisition of 10% shareholding in Tata Play by Tata Sons.Tata Sons is an investment holding company, which is registered as a core investment company with the Reserve Bank of India and classified as a “Systemically Important Non-Deposit Taking Core Investment Company”.Tata Play, formerly known as Tata Sky, is one of India’s leading content distribution platforms pro..

Next Story
Infrastructure Urban

DARPG Releases 31st CPGRAMS Report for February 2025

The Department of Administrative Reforms and Public Grievances (DARPG) has released the 31st monthly report on the Centralised Public Grievance Redress and Monitoring System (CPGRAMS) for States and Union Territories (UTs) for February 2025. The report provides insights into the volume of grievances received, disposal rates, and major grievance categories across different states and UTs. Key Highlights from the Report Grievance Statistics: A total of 52,464 grievances were received in February 2025. 50,088 grievances were redressed during the month. As of 28th February 2025, the total pen..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?